Amid sharp rise in COVID-19 cases In India, vaccination for kids becomes a major issue

Image source - Livemint

India reported 47,029 coronavirus cases and 509 deaths in the last 24 hours, ending at 8:00 a.m. on Thursday. Out of the new cases and deaths reported, Kerala reported 32,803 fresh cases and 173 deaths yesterday.

Kerala is witnessing a great surge in covid-19 cases. Now every 6 out of 10 new cases in India are from Kerala. As of August 28, 64.2 percent of India's average new cases were from Kerala.

One of the ministers of the ruling party admitted that India is taking precautions for the upcoming third wave of coronavirus, which has been already predicted and hence is going to affect children the most. So vaccination becomes important.

The Drugs Controller General of India (DCGI) yesterday granted permission to Hyderabad-based biological enterprise to conduct phase II/III clinical trials of its 'Made in India' COVID-19 vaccine on children aged between 5 and 18 years with certain conditions.

Biological E will supply 30 crore doses of Corbevax to the central government by December as announced by the Union Health Minister in June. "The ministry finalized arrangements with the Hyderabad based vaccine manufacturer to reserve 30 crore vaccine doses", said an official.

So far, indigenously developed Zydus Cadila's needle-free covid-19 vaccine ZyCoV-D has received Emergency Use Authorisation from the drug regulator, making it the first vaccine to be administered in the age group of 12 to 18 years in the country.

As of now, the surge in COVID-19 cases may be worrying and may show the culmination of the third wave of the virus. Proper precautions and large-scale vaccination are the only visible solutions.

4 views0 comments